Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

18F-fluciclovine

  • Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PET
    You have access
    Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET
    Ali Nabavizadeh, Stephen J. Bagley, Robert K. Doot, Jeffrey B. Ware, Anthony J. Young, Satyam Ghodasara, Chao Zhao, Hannah Anderson, Erin Schubert, Erica L. Carpenter, Jacob Till, Fraser Henderson, Austin R. Pantel, H. Isaac Chen, John Y.K. Lee, Nduka M. Amankulor, Donald M. O’Rourke, Arati Desai, MacLean P. Nasrallah and Steven Brem
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 852-858; DOI: https://doi.org/10.2967/jnumed.122.264812
  • 
    Detection of Additional Primary Neoplasms on <sup>18</sup>F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
    You have access
    Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
    Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti and Richard L. Wahl
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 713-719; DOI: https://doi.org/10.2967/jnumed.121.262647
  • Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on <sup>18</sup>F-Fluciclovine PET/CT Guidance
    You have access
    Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
    Olayinka A. Abiodun-Ojo, Ashesh B. Jani, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Oluwaseun A. Odewole, Funmilayo I. Tade, Shreyas S. Joshi, Viraj A. Master, Bridget Fielder, Raghuveer K. Halkar, Chao Zhang, Subir Goyal, Mark M. Goodman and David M. Schuster
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1089-1096; DOI: https://doi.org/10.2967/jnumed.120.256784
  • You have access
    Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center
    Matthew D. Bucknor, Daphne Y. Lichtensztajn, Tracy K. Lin, Hala T. Borno, Scarlett L. Gomez and Thomas A. Hope
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 695-699; DOI: https://doi.org/10.2967/jnumed.120.251751
  • You have access
    18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
    Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  • You have access
    Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
    Ephraim E. Parent and David M. Schuster
    Journal of Nuclear Medicine May 1, 2018, 59 (5) 733-739; DOI: https://doi.org/10.2967/jnumed.117.204032
  • You have access
    Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
    Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen and Penelope Ward
    Journal of Nuclear Medicine October 1, 2017, 58 (10) 1596-1602; DOI: https://doi.org/10.2967/jnumed.116.188375
  • You have access
    Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers
    Gary A. Ulaner, Debra A. Goldman, Adriana Corben, Serge K. Lyashchenko, Mithat Gönen, Jason S. Lewis and Maura Dickler
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1037-1042; DOI: https://doi.org/10.2967/jnumed.116.183335
  • You have access
    Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs
    David M. Schuster, Cristina Nanni and Stefano Fanti
    Journal of Nuclear Medicine October 1, 2016, 57 (Supplement 3) 61S-66S; DOI: https://doi.org/10.2967/jnumed.115.170209
  • You have access
    Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
    Gary A. Ulaner, Debra A. Goldman, Mithat Gönen, Hanh Pham, Raychel Castillo, Serge K. Lyashchenko, Jason S. Lewis and Chau Dang
    Journal of Nuclear Medicine September 1, 2016, 57 (9) 1350-1356; DOI: https://doi.org/10.2967/jnumed.115.170456
SNMMI

© 2025 SNMMI

Powered by HighWire